Analysing the role of C16orf54 in tumour diagnosis using ROC curve revealed that C16orf54 could distinguish tumour tissues, such as LAML, TCGT, LUSC, and PAAD, from normal tissues with high accuracy, which suggests C16orf5 as a potential biomarker for tumour diagnosis. Here, CDIP1 is linked to pancreatic adenocarcinoma.